Bioavailability of quercetin in healthy men and women

Bioavailability of quercetin in healthy men and women - BV-study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00004350

Enrollment

Registered

2012-08-29

Start date

2012-09-24

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy participants

Interventions

Group 1: quercetin (dihydrate), oral bolus intake of 150 mg quercetin, fasting state, intake with 300 mL water Group 2: quercetin (onion skin extract), oral bolus intake of 150 mg quercetin, fasting s

Eligibility

Sex/Gender

All

Age

19 Years to 35 Years

Inclusion criteria

Inclusion criteria: Healthy, normal-weight, non-smoking

Exclusion criteria

Exclusion criteria: smoking, overweight/obesity, intake of drugs or dietary supplements, metabolic and endocrine diseases, malabsorption syndromes, alcohol abuse

Design outcomes

Primary

Measure	Time frame
concentration of quercetin in plasma (before bolus intake and after 0,5, 1, 1,5, 2, 3, 4, 5, 6, 7, 8, 9, 24 h)	—

Secondary

Measure	Time frame
not defined	—

Countries

Germany

Contacts

Public ContactSarah Egert

Universität Bonn IEL Ernährungsphysiologie

s.egert@uni-bonn.de0228 / 73 3748

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026